nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A composite disease activity index for early drug development in ulcerative colitis: development and validation of the UC-100 score
|
Jairath, Vipul |
|
2019 |
4 |
1 |
p. 63-70 |
artikel |
2 |
Artificial intelligence and computer-aided diagnosis in colonoscopy: current evidence and future directions
|
Ahmad, Omer F |
|
2019 |
4 |
1 |
p. 71-80 |
artikel |
3 |
Bowel cancer diagnostic services in the UK: at full capacity?
|
Burki, Talha Khan |
|
2019 |
4 |
1 |
p. 15 |
artikel |
4 |
Case finding and therapy for chronic viral hepatitis in primary care (HepFREE): a cluster-randomised controlled trial
|
Flanagan, Stuart |
|
2019 |
4 |
1 |
p. 32-44 |
artikel |
5 |
Direct-acting antivirals for chronic hepatitis C virus genotype 5 and 6 infections
|
Torres, Maria Corina Plaz |
|
2019 |
4 |
1 |
p. 5-6 |
artikel |
6 |
Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 or 6 infection (ENDURANCE-5,6): an open-label, multicentre, phase 3b trial
|
Asselah, Tarik |
|
2019 |
4 |
1 |
p. 45-51 |
artikel |
7 |
Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial
|
Flik, Carla E |
|
2019 |
4 |
1 |
p. 20-31 |
artikel |
8 |
Fermented foods: fad or favourable addition to the diet?
|
Staudacher, Heidi M |
|
2019 |
4 |
1 |
p. 19 |
artikel |
9 |
Hepatitis case finding among migrants in primary care
|
Hickman, Matthew |
|
2019 |
4 |
1 |
p. 3-4 |
artikel |
10 |
Hepatitis C incidence 3 years after implementation of an educate, test, and treat programme in an Egyptian village
|
Shiha, Gamal |
|
2019 |
4 |
1 |
p. 13-14 |
artikel |
11 |
Ironing out unmet need in genetic haemochromatosis
|
The Lancet Gastroenterology & Hepatology, |
|
2019 |
4 |
1 |
p. 1 |
artikel |
12 |
Is hypnotherapy helpful for irritable bowel syndrome in primary and secondary care?
|
Palsson, Olafur S |
|
2019 |
4 |
1 |
p. 2-3 |
artikel |
13 |
Pharmacy-led hepatitis C treatment pathways to help ensure elimination
|
Gunn, Jack |
|
2019 |
4 |
1 |
p. 12-13 |
artikel |
14 |
Place of death and factors associated with hospital death in patients who have died from liver disease in England: a national population-based study
|
Peng, Jen-Kuei |
|
2019 |
4 |
1 |
p. 52-62 |
artikel |
15 |
Preoperative drainage for perihilar cholangiocarcinoma
|
Odisio, Bruno C |
|
2019 |
4 |
1 |
p. 10-11 |
artikel |
16 |
Preoperative drainage for perihilar cholangiocarcinoma
|
Singh, Akash |
|
2019 |
4 |
1 |
p. 10 |
artikel |
17 |
Preoperative drainage for perihilar cholangiocarcinoma – Authors' reply
|
Coelen, Robert J S |
|
2019 |
4 |
1 |
p. 11-12 |
artikel |
18 |
Research in brief
|
Baker, Holly |
|
2019 |
4 |
1 |
p. 18 |
artikel |
19 |
Towards more efficient assessment of ulcerative colitis drugs
|
Carbonnel, Franck |
|
2019 |
4 |
1 |
p. 8-9 |
artikel |
20 |
UEG Week 2018
|
Brierley, Rob |
|
2019 |
4 |
1 |
p. 16-17 |
artikel |
21 |
Unmet needs in end-of-life care for chronic liver disease
|
Thomas, Tom |
|
2019 |
4 |
1 |
p. 6-7 |
artikel |